FFPE Tissues You Can Trust
—Backed by Quality, Pathology, and AI

Accelerate your oncology, immunology, and other disease area programs with the largest and most comprehensively characterized FFPE inventory—backed by industry-leading acceptance rates, rigorous 12-point quality checks, triple pathology review, and AI-powered tumor quantification.

Access to FFPE tissue should be as diverse as the disease itself.

Discovery Life Sciences takes a Science at Your Service™ approach to provide scientists worldwide with a diverse range of highly characterized (hyper annotated®) human FFPE biospecimens to accelerate all your programs.

RELIABLE FFPE SELECTION WITH DIGITAL H&E SLIDES

ACTIONABLE SAMPLE DATA

SAMPLE INTEGRITY

QUICK SAMPLE DELIVERY

SORTABLE INVENTORY REPORT

UNMATCHED ACCESS

Featured FFPE Products

STAND-ALONE FFPE

3x pathologist-reviewed FFPE tissue with 40x digital H&E scans available from over 30,000 cases.

FFPE + Matched DTCs

Discovery’s quality FFPE tissue matched with dissociated tumor cells with cell count and HLA-typing

SpecimenSeq™ FFPE

NGS-characterized FFPE tissue. >40,000+ detections of 500+ specific genes across 19 oncology indications and 900+ unique patients.

FFPE + Matched Flash Frozen Tissue

Mirrored pairs of consented flash frozen tissue and FFPE. More than 175mg of flash frozen tissue & full FFPE blocks.

SpecimenSeq™ FFPE + Matched Plasma

1,200+ detections of 54 clinically relevant genes across 30 oncology indications and 200+ unique patients.

FFPE + Matched Plasma + Buffy Coat

Quality Discovery Life Sciences FFPE with matched plasma (Streck and K2EDTA available) and buffy coat.

AI-Annotated FFPE Tissues with Precise Tumor Content Quantification

Discovery has deployed PathAI’s AISight® workflow solutions in our pathology workflow, enabling a new level of precision in tumor content quantification.  AI-annotation is able to calculate tumor percent at a decimal-point level of precision, surpassing the traditional qualitative assessments of pathologists and empowering faster turnaround times for large-scale research projects.

ArtifactDetect automatically identifies potential histology and scanning QC issues.
TumorDetect identifies and quantifies cancer area, cancer stroma, and necrosis.

AISight® is for Research Use Only in the US; AISight® Dx is CE-IVD marked in the EEA, UK, and Switzerland. ArtifactDetect and TumorDetect are research use only products available on AISight® Image Management System, not for use in diagnostic procedures.

Get More from Your FFPE Tissue

Discovery’s proprietary dual nucleic acid extraction enables reliable, reproducible low-input RNA-Seq

FFPE Technical Resources

White Paper

Optimized Methods For Sequencing RNA From FFPE Samples White Papers

Webinar

ASHG 2019 Presentation Webinars & Videos

Poster

AACR 2023 - Characterization of a Novel Immunohistochemistry (IHC) Assay for CEACAM5 Using a Commercial Antibody Abstracts & Posters

Need molecular characterization for your FFPE tissue?

While our biospecimens are highly characterized, we also provide streamlined multi-omic analyses to further characterize biospecimens from our inventory or from your studies via our global CLIA / CAP service laboratories.*

DISCOVERY GENOMICS

MOLECULAR PATHOLOGY

*Not all service laboratories have CLIA certification or CAP accreditation. Inquire to learn more.

Get Help Finding the Right FFPE Product

Expertise across different molecular pathology platforms in CLIA-certified, CAP-accredited, and GCLP-compliant laboratories.

Contact Us Today

Quick Links

Technologies

Development and Clinical
Trial Solutions

Privacy Settings